[Home ] [Archive]   [ فارسی ]  
:: Main :: About :: Current Issue :: Archive :: Search :: Submit :: Contact ::
Main Menu
Home::
Journal Information::
Articles archive::
Publication Ethics::
Peer Review Process::
Indexing Databases::
For Authors::
For Reviewers::
Subscription::
Contact us::
Site Facilities::
::
Google Scholar Metrics

Citation Indices from GS

AllSince 2019
Citations63033611
h-index2719
i10-index18679

..
Search in website

Advanced Search
..
Receive site information
Enter your Email in the following box to receive the site news and information.
..
Registered in

AWT IMAGE

AWT IMAGE

..
:: Volume 22, Issue 7 (in press 2015) ::
Journal of Ilam University of Medical Sciences 2015, 22(7): 136-145 Back to browse issues page
Estimation of Absorbed Dose to the Organs with High Risk of Radiation Exposure During External Radiotherapy of Esophageal Cancer
Abstract:   (6449 Views)
Introduction: External radiotherapy is one of the treatments of cancer in which the risk of radiation exposure of organs is a continue concern. The goal of present study was to measure surface and depth doses in an anthropomorphic phantom and surface dose in patients suffering upper esophageal cancer undergoing radiotherapy. Materials and Methods: In this study, surface and depth doses and surface doses was measured in phantom and patients, respectively. The phantom had some places to insert thermoluminescence dosimeters (TLDs) in eye, parotid, submandibular glands, and thyroid, spine, sternum and trachea areas. As this treatment performs in two phases, the dosimetry was done in both phases. In phase I, treatment was performed using parallel opposed (AP-PA) technique with a dose of 2 Gy/ fraction and in phase II, treatment was done with three beam technique (an oblique and AP-PA) with a dose of 1.8 Gy/fraction in 5 fractions. Findings: In regions out of treatment field such as parotid and eye, measured doses were in the range of 1.36-7.5 cGy. Thyroid doses differ in two phases in phase I thyroid was in treatment field and its dose in the phantom was 30.84±0.88 cGy and in phase II it was in the outside of the treatment field and its dose was 5.04±0.11 cGy, whereas in patients in phase I the dose was 107.78±10.84 cGy and in phase II was 6.73±1.17 cGy. In other measurement points, there were no significant differences between measured and calculated values with TLDs and treatment planning system, respectively. Discussion & Conclusion: Comparing calculated doses obtained from treatment planning system and measured doses by TLDs, it was observed that these values have little differences in regions out of the treatment field which is due to scattered radiation. According to our results, given the critical role of thyroid and its high risk of radiation exposure, it is necessary to consider thyroid for defining radiation fields.
Keywords: Esophageal neoplasms, radiotherapy, thermoluminescent dosimetry, phantom, organs at risk
Full-Text [PDF 693 kb]   (2214 Downloads)    
Type of Study: Research | Subject: biophysics
Received: 2015/03/13 | Accepted: 2015/03/13 | Published: 2015/03/13
Add your comments about this article
Your username or Email:

CAPTCHA


XML   Persian Abstract   Print


Download citation:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:

Estimation of Absorbed Dose to the Organs with High Risk of Radiation Exposure During External Radiotherapy of Esophageal Cancer. J. Ilam Uni. Med. Sci. 2015; 22 (7) :136-145
URL: http://sjimu.medilam.ac.ir/article-1-2588-en.html


Rights and permissions
Creative Commons License This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
Volume 22, Issue 7 (in press 2015) Back to browse issues page
مجله دانشگاه علوم پزشکی ایلام Journal of Ilam University of Medical Sciences
Persian site map - English site map - Created in 0.16 seconds with 41 queries by YEKTAWEB 4643